Nephrocalcin Inhibitors
Chemical inhibitors of Nephrocalcin can effectively reduce its activity by various mechanisms, primarily through the sequestration of calcium ions which are vital for the protein's function. Magnesium chloride, for example, competes with calcium ions at the binding sites of Nephrocalcin, thereby reducing the protein's ability to bind calcium and form complexes. Similarly, phosphate, by binding to calcium, decreases the availability of this crucial ion, impeding Nephrocalcin's function. Chelating agents such as EDTA and EGTA are particularly potent as they can form strong complexes with calcium ions, sequestering them away from Nephrocalcin and thus inhibiting its activity. The chelation process effectively reduces the concentration of free calcium ions in the vicinity of Nephrocalcin, rendering it inactive as it relies on these ions for its function.
Further down the list of inhibitors, citrate and BAPTA operate on the same principle of calcium ion sequestration, with citrate forming complexes with calcium and BAPTA acting as a calcium chelator. Sodium oxalate presents a different approach by precipitating with calcium ions to form calcium oxalate, thus diminishing the pool of free calcium necessary for Nephrocalcin activity. Zinc acetate provides zinc ions, which can outcompete calcium ions for the binding sites on Nephrocalcin, thereby inhibiting the protein's calcium-binding function. Additionally, diphosphate and alendronate, similar to phosphate, can bind calcium ions, further reducing their free concentration and inhibiting Nephrocalcin. Hydroxyapatite, due to its affinity for calcium ions, can also bind to them and curb the bioavailability of calcium for Nephrocalcin, leading to inhibition of the protein. Lastly, Ferrozine, while not a direct calcium-binding inhibitor, can complex with other metal ions such as iron, which can indirectly affect Nephrocalcin's structure and its interaction with calcium ions. Each of these chemical inhibitors, through their interaction with calcium ions, can effectively inhibit the functionality of Nephrocalcin.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Magnesium chloride | 7786-30-3 | sc-255260C sc-255260B sc-255260 sc-255260A | 10 g 25 g 100 g 500 g | $28.00 $35.00 $48.00 $125.00 | 2 | |
Magnesium ions can inhibit Nephrocalcin by competing with calcium binding sites, thus reducing its ability to bind calcium and form complexes. This inhibition is relevant as Nephrocalcin functions by binding calcium ions. | ||||||
Sodium phosphate | 7601-54-9 | sc-251041 sc-251041A | 25 g 500 g | $42.00 $47.00 | ||
Phosphate can bind to calcium, making it unavailable to interact with Nephrocalcin, which relies on calcium for its function. The reduction in free calcium concentration effectively inhibits Nephrocalcin′s ability to bind calcium and form complexes. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
EGTA preferentially binds to calcium ions over magnesium ions, which can inhibit Nephrocalcin by reducing the availability of calcium for binding. Since Nephrocalcin activity is calcium-dependent, EGTA's chelation of these ions inhibits the protein's function. | ||||||
Citric Acid, Anhydrous | 77-92-9 | sc-211113 sc-211113A sc-211113B sc-211113C sc-211113D | 500 g 1 kg 5 kg 10 kg 25 kg | $50.00 $110.00 $145.00 $248.00 $598.00 | 1 | |
Citrate can form complexes with calcium ions, decreasing the concentration of free calcium required for Nephrocalcin's activity. By binding to calcium, citrate inhibits the ability of Nephrocalcin to interact with these ions, which is necessary for its function. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
BAPTA is a calcium chelator that inhibits Nephrocalcin by binding to calcium ions, thus preventing the interaction of calcium with Nephrocalcin, which is essential for its calcium-binding function. | ||||||
Sodium oxalate | 62-76-0 | sc-203396 sc-203396A | 100 g 500 g | $43.00 $139.00 | 5 | |
Sodium Oxalate inhibits Nephrocalcin by precipitating with calcium ions to form calcium oxalate, reducing the free calcium ion concentration available for Nephrocalcin binding and thus inhibiting its function. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can outcompete calcium ions for binding sites on Nephrocalcin, inhibiting its calcium-binding function. The presence of zinc acetate provides zinc ions that can inhibit Nephrocalcin by altering its conformation and preventing calcium binding. | ||||||
Alendronate acid | 66376-36-1 | sc-337520 | 5 g | $135.00 | 2 | |
Alendronate, a bisphosphonate, can complex with calcium ions, decreasing their availability for Nephrocalcin binding, which is crucial for the protein's function. The inhibition occurs due to the reduction in free calcium concentration necessary for Nephrocalcin's activity. | ||||||
Hydroxylapatite, Ceramic | 1306-06-5 | sc-295168 sc-295168A | 10 g 25 g | $97.00 $376.00 | ||
Hydroxyapatite can bind calcium ions, thereby inhibiting Nephrocalcin by sequestering calcium and reducing the ion′s availability for interaction with the protein. Since Nephrocalcin requires calcium for function, hydroxyapatite′s binding to these ions results in functional inhibition of the protein. | ||||||